Current issues in quality improvement in cystic fibrosis

被引:40
作者
Quinton, Hebe B.
O'Connor, Gerald T.
机构
[1] Dartmouth Med Sch, Dept Med, Clin Res Sect, Lebanon, NH 03756 USA
[2] Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Ctr Evaluat Clin Sci, Lebanon, NH 03756 USA
关键词
D O I
10.1016/j.ccm.2007.02.013
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The modern history of cystic fibrosis (CF) is one of continuous improvement. Guidelines and evidence-based medicine provide a general roadmap for directing improvement efforts. Data and measurement are central to quality improvement QI), a way of keeping score and staying on track. This article describes the history and context of QI in CF, the use of guidelines and data with some examples from the work of one regional consortium, some approaches to developing QI skills with a view to implementing and managing desired changes in CF clinic settings, and the potential benefits and impact of public reporting and data transparency.
引用
收藏
页码:459 / +
页数:15
相关论文
共 40 条
[21]   PERSON-TO-PERSON TRANSMISSION OF PSEUDOMONAS-CEPACIA BETWEEN PATIENTS WITH CYSTIC-FIBROSIS [J].
LIPUMA, JJ ;
DASEN, SE ;
NIELSON, DW ;
STERN, RC ;
STULL, TL .
LANCET, 1990, 336 (8723) :1094-1096
[22]   LONG-TERM EFFECTS OF INHALED TOBRAMYCIN IN PATIENTS WITH CYSTIC-FIBROSIS COLONIZED WITH PSEUDOMONAS-AERUGINOSA [J].
MACLUSKY, IB ;
GOLD, R ;
COREY, M ;
LEVISON, H .
PEDIATRIC PULMONOLOGY, 1989, 7 (01) :42-48
[23]   Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study [J].
Mahadeva, R ;
Webb, K ;
Westerbeek, RC ;
Carroll, NR ;
Dodd, ME ;
Bilton, D ;
Lomas, DA .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7147) :1771-+
[24]  
Marmot Michael., 2004, STATUS SYNDROME SOCI
[25]  
MCPHERSON C, 1990, AM J DIS CHILD, V144, P1311
[26]   Median household income and mortality rate in cystic fibrosis [J].
O'Connor, GT ;
Quinton, HB ;
Kneeland, T ;
Kahn, R ;
Lever, T ;
Maddock, J ;
Robichaud, P ;
Detzer, M ;
Swartz, DR .
PEDIATRICS, 2003, 111 (04) :e333-339
[27]   Case-mix adjustment for evaluation of mortality in cystic fibrosis [J].
O'Connor, GT ;
Quinton, HB ;
Kahn, R ;
Robichaud, P ;
Maddock, J ;
Lever, T ;
Detzer, M ;
Brooks, JG .
PEDIATRIC PULMONOLOGY, 2002, 33 (02) :99-105
[28]  
PARKER HW, 1998, PEDIAT PULMONO A S17, V701, P408
[29]   Intermittent administration of inhaled tobramycin in patients with cystic fibrosis [J].
Ramsey, BW ;
Pepe, MS ;
Quan, JM ;
Otto, KL ;
Montgomery, AB ;
Williams-Warren, J ;
Vasiljev-K, M ;
Borowitz, D ;
Bowman, CM ;
Marshall, BC ;
Marshall, S ;
Smith, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (01) :23-30
[30]  
STALLINGS VA, UNPUB EVIDENCE BASED